Related Experiment Video
Updated: Dec 10, 2025
09:41
Hemocompatibility Testing of Blood-Contacting Implants in a Flow Loop Model Mimicking Human Blood Flow
Published on: March 5, 2020
9.9K
Engineering Approaches to Prevent Blood Clotting from Medical Implants
Aaron C Wilson1, Pierre F Neuenschwander2, Shih-Feng Chou1
1Department of Mechanical Engineering, The University of Texas at Tyler, USA.
Archives in Biomedical Engineering & Biotechnology
|September 1, 2020
Summary
Improving vascular stents with advanced coatings enhances hemocompatibility. Engineering approaches like drug-eluting and biomimetic coatings reduce inflammation and improve implant longevity.
Area of Science:
- Biomedical Engineering
- Materials Science
Background:
- Vascular stents are crucial for treating blood clots but face challenges like inflammation and protein adsorption.
- Traditional metallic stents exhibit limitations despite anticoagulation improvements.
Purpose of the Study:
- To explore engineering strategies for enhancing medical implant hemocompatibility.
- To review advancements in coatings for vascular stents and other medical devices.
Main Methods:
- Discussing drug-eluting materials and polymeric/non-polymeric coatings.
- Investigating surface modifications for improved biomaterial performance.
- Highlighting coatings with slow degradation and drug/biomacromolecule loading capabilities.
Main Results:
- Engineered coatings significantly improve hemocompatibility of medical implants.
- Advanced coatings can mimic surrounding cellular architecture.
- Potential for coatings to reduce adverse biological responses to implants.
Conclusions:
- Hemocompatible coatings represent a significant advancement in medical implant technology.
- Future trends focus on developing novel coating materials for extended implant lifespan.
- Biomimetic and drug-eluting coatings offer promising solutions for implant-related complications.
More Related Videos
Related Concept Videos
01:29Venous Thrombosis III: Interprofessional Care
177
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
177
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.4K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.4K
01:30Bacterial Signaling
39.3K
Bacterial signaling can occur within bacteria (intracellular) or between bacteria (intercellular). At times, a group of bacteria behaves like a community. To achieve this, they engage in quorum sensing, the perception of higher cell density that causes changes in gene expression. Quorum sensing involves both extracellular and intracellular signaling. The signaling cascade starts with a molecule called an autoinducer (AI). Individual bacteria produce AIs that move out of the bacterial cell...
39.3K
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
917
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
917
01:16Clot Retraction and Fibrinolysis
8.0K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
8.0K